1. 1. Multi-drug resistant tuberculosis. ICMR. 1999; 29:105-114.
2. 2. Prasad R, Singh A, Srivastava R, Kushwaha R, Garg R, Hosmane G B, Jain A. Adverse drug reaction in treatment of multidrug resistant tuberculosis. Chest. 2013; 144:390A.
3. 3. Prasad R, Verma S K, Sahai S, Kumar S, Jain A. Efficacy and safety of kanamycin, ethionamide, PAS, and cycloserine in multidrug resistant pulmonary tuberculosis patients. Ind J Chest Dis Allied Sci. 2006; 48:183-186.
4. 4. Tsukamura M, Mizuno S. Cross-resistant relationships among the aminoglycoside antibiotics in Mycobacterium tuberculosis. J Gen Microbiol. 1975; 88:269-274.
5. 5. Venkataraman P, Paramasivan CN, Prabhakar R. In vitro activity of rifampicin, rifapentine and rifabutin against south Indian isolates of Mycobacteirum tuberculosis. Ind J Tub. 1993; 40:171-175.